C Champions Oncology Inc
C
Closed
SectorHealthcare
5.68 1.79
Overview
Share price change
24h
Min
5.54
Max
5.76
Income | -514K -278K |
|---|---|
Sales | 1.5M 17M |
P/E Sector Avg | 35.118 49.888 |
EPS | -0.02 |
Profit margin | -1.679 |
Employees | 213 |
EBITDA | -458K 154K |
Next Earnings | 22 lip 2026 |
|---|
Market Cap | -1.8M 81M |
|---|---|
Previous open | 3.89 |
Previous close | 5.68 |
News Sentiment
By Acuity
100%
0%
325 / 344 Ranking in Healthcare
Champions Oncology Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Champions Oncology Inc Forecast
Sentiment
By Acuity
325 / 344 Ranking in Healthcare
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
